Common Stock

The Reporting Person acquired a $250,000 principal amount convertible promissory note on October 31, 2024, as amended and restated, the Note, from the Issuer for aggregate consideration of $225,000. The Note bears interest at 8%. On August 15, 2025, the Reporting Person converted approximately $250,000 of principal and $27,777.63 of accrued interest under a convertible promissory note, dated October 31, 2024, as amended and restated, outstanding under the Note, into 526,094 shares of the Issuers common stock, at a conversion price of $0.528 per share. The issuance of shares of common stock upon the conversion of the Note by the Reporting Person was approved by the Issuers stockholders at a special meeting held on February 21, 2025. The conversion price in effect at the time of conversion pursuant to the terms of the Note was $0.528 per share.

The Note was issued on October 31, 2024, and was convertible into shares of common stock at the election of the holder anytime thereafter at an initial conversion price of $3.402 per share, subject to the full ratchet anti dilution provisions contained therein, subject to a floor price of $0.528 per share, and subject to approval by the stockholders of the Issuer. The Issuer's stockholders approved the issuance of shares of common stock upon the conversion of the Note at a special meeting held on February 21, 2025.


The transaction was executed in multiple trades at prices ranging from $10.925 to $10.98; the price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide full information regarding the number of shares and prices at which were effected upon request to the SEC staff.

/s/ Gaye Wilkerson, as attorney in fact for Vincent J. Intrieri


The Shares being reported represent Restricted Stock Units ("RSUs") awarded under the Reservoir Media, Inc. 2021 Omnibus Incentive Plan (the "Plan") to Ryan P. Taylor. Each RSU represents a contingent right to receive one share of common stock, $0.0001 par value per share (the "Common Stock"), of Reservoir Media, Inc. (the "Issuer"). The RSUs were issued in connection with Mr. Taylor's annual equity compensation for service as a non-employee director. The RSUs will vest on July 28, 2026, subject to Mr. Taylor's continued service on the board of directors (the "Board") of the Issuer on such date.

The Shares being reported represent Deferred Stock Units ("DSUs") awarded under the Reservoir Media, Inc. 2021 Omnibus Incentive Plan (the "Plan") to Ryan P. Taylor. Each DSU is the economic equivalent of one share of common stock, $0.0001 par value per share (the "Common Stock"), of Reservoir Media, Inc. (the "Issuer"). The DSUs were issued in connection with Mr. Taylor's quarterly compensation for service as a non-employee director. Mr. Taylor elected to receive payment of his quarterly compensation in DSUs in lieu of cash. The DSUs will be settled in shares of Common Stock on July 28, 2026 (the "Settlement Date").

The number of DSUs received was calculated based on $7.67, which was the closing price of the Issuer's Common Stock on the date of grant.

Amount of securities beneficially owned following the reported transactions includes 10,430 shares of Common Stock underlying RSUs and 3,852 shares of Common Stock underlying DSUs awarded to Mr. Taylor for service as a non-employee director of the Issuer.  Due to his position as the manager of the general partner of a manager of ER Reservoir LLC (the "Fund"), Mr. Taylor has directed the Issuer to transfer shares issued upon settlement of the RSUs and DSUs into the account of the Fund on the applicable Settlement Date. Mr. Taylor disclaims beneficial ownership of the underlying shares except to the extent of his pecuniary interest therein.

The Reporting Persons listed on this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 shall not be deemed to be an admission that the Reporting Persons are members of such group.

The amount of securities shown in this row is owned directly by the Fund. As a manager of the Fund, Richmond Hill Investments, LLC (the "RHI Manager") may be deemed to be a beneficial owner of 9,896,145 of the Issuer's securities held by the Fund. As a manager of the Fund, Richmond Hill Investment Co., LP (the "RHIC Manager") may be deemed to be a beneficial owner of 3,753,710 of the Issuer's securities held by the Fund. As the general partner of the RHIC Manager, Richmond Hill Capital Management, LLC (the "General Partner") may be deemed to be a beneficial owner of 3,753,710 of the Issuer's securities held by the Fund. As the manager of the RHI Manager, Essex Equity Holdings, LLC (the "EEH Manager") may be deemed to be a beneficial owner of 9,896,145 of the Issuer's securities held by the Fund. (continued in footnote 7)

(Continued from footnote 6) As the manager of the EEH Manager, John D. Liu may be deemed to be a beneficial owner of 9,896,145 of the Issuer's securities held by the Fund. As the manager of the General Partner, Ryan P. Taylor may be deemed to be a beneficial owner of 3,753,710 of the Issuer's securities held by the Fund. The amount of securities shown in this row also reflects a transfer of a total of 57,062 shares of Common Stock received upon the settlement of previously issued RSUs and DSUs that Mr. Taylor directed to be transferred to the account of the Fund due to his position as the manager of the general partner of a manager of the Fund. Each of the RHI Manager, the RHIC Manager, the General Partner, the EEH Manager, Mr. Liu and Mr. Taylor disclaims any beneficial ownership of any of the Issuer's securities reported herein for purposes of Section 16 of the Exchange Act or otherwise, except to the extent of its or his respective pecuniary interest therein.

The Reporting Persons listed on this Form 4 may be deemed members of a group with Essex Equity Joint Investment Vehicle, LLC and certain of its affiliates (collectively, the "Essex Entities") and Richmond Hill Capital Partners, LP and certain of its affiliates (collectively, the "RHCP Entities"), which have each previously filed a Form 3 and Form 4's with respect to equity securities of the Issuer. The filing of this Form 4 shall not be deemed to be an admission that the Reporting Persons are members of such a group with any of the Essex Entities or the RHCP Entities and the Reporting Persons disclaim beneficial ownership of any securities beneficially owned by the Essex Entities and the RHCP Entities, except to the extent of their pecuniary interests therein.


The price reflects a weighted average of sales made at prices ranging from $11.4753 to $11.51. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Shares are held by the Jason R. Waldron Revocable Trust, of which the Reporting Person is the trustee.

The price reflects a weighted average of sales made at prices ranging from $11.58 to $11.665. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

The trading symbols for the Issuer's classes of common shares are LBTYA, LBTYB, and LBTYK.


Shares sold pursuant to a 10b5-1 Trading Plan.


Adoption date of referenced 10b5-1(c) plan is: 05-08-2025

Included in this amount are 91,210 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 38,994 shares held directly by the reporting person.

Includes 387 shares acquired pursuant to the Issuer's employee stock purchase plan.

/s/ Nicole Strydom, Attorney-in-Fact for Arun Rajan


Common Stock

Common Stock

Common Stock

Shares held by Klein 2024 Revocable Trust dated February 25, 2024 (the "Trust), of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.

1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.

1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date.


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2024.

/s/ Frederick Williams, Attorney-in-Fact


Represents the number of shares withheld to cover tax liability incurred upon the vesting of previously reported restricted stock units.  All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person.

Includes restricted stock units scheduled to vest in the future.

/s/ John A. Mikowski, Deputy General Counsel and Assistant Corporate Secretary, as Attorney-in-Fact


Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.4850 to $105.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

A portion of these shares represent RSUs. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.78 to $106.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.02 to $107.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Juliana Chen as attorney-in-fact for Reporting Person


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.92 to $15.40, inclusive. The reporting person undertakes to provide to Lightbridge Corporation, any security holder of Lightbridge Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3348 to $0.3649 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.


Common stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.

8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.

Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.

Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.

Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.

Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.

The price reported is a weighted average price. These shares were purchased in multiple transactions at $4.50.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.34 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc.  (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.23 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc.  (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


Reflects a reduction of shares of restricted stock withheld to cover taxes payable by the reporting person due to the August 15, 2025 vesting of a portion of the August 15, 2022 restricted stock grant.


The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2025.


Common Stock

Common Stock

The price reported is an average of the total transactions executed for the day, with the individual transactions ranging from a low of $244.47 per share to a high of $244.70 per share.

The reporting person was granted an option to purchase stock under the Carpenter Technology Corporation Stock Based Compensation Plan for Non-Employee Directors.


Common Stock Par Value $0.10 Per Share

Restricted stock units convert into common stock on a one-for-one basis.

The 620 reflected on this table represents the shares withheld to pay the Reporting Person's federal, state, and Federal Insurance Contributions Act ("FICA") tax.

This Form 4/A is being filed as an amendment to the Form 4 filed by Comtech Telecommunications Corp on August 14, 2025 (the "Original Report"), solely to correct an error in the amount of shares withheld to pay the Reporting Person's federal, state, and Federal Insurance Contributions Act ("FICA") tax reported on Table 1. There are no other changes to the Original Report.

This transaction represents the vesting of 1,374 of the 4,123 restricted stock units issued to the Reporting Person on August 12, 2022.

/s/ Michael C. Shay, Attorney-in-Fact for Daniel Gizinski


Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $207.80 to $208.59. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.


In connection with the vesting of previously reported restricted stock units.

The reporting person was granted restricted stock units under the Carpenter Technology Corporation Stock-Based Incentive Compensation Plan for Officers and Key Employees.

Includes shares acquired under the Retirement Plan of Carpenter Technology Corporation.  The share balance under the Retirement Plan of Carpenter Technology fluctuates due to rounding differences produced by the Plan's method of estimating shares.


2025 Cash Settled Restricted Stock Units

Common Stock

Each unit is the economic equivalent of one share of Bank of America Corporation common stock.

On February 14, 2025, the reporting person was granted units, vesting and payable solely in cash as follows: 1/12th of the stock units vest and become payable on the 15th day of each month during the 12-month period beginning in March 2025 and ending in February 2026.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.18, inclusive. The reporting person undertakes to provide to Dolphin Entertainment, Inc., any security holder of Dolphin Entertainment, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote (1) to this Form 4.

Dolphin Entertainment, LLC is an entity wholly owned by William O'Dowd IV.

Dolphin Digital Media Holdings LLC is an entity wholly owned by William O'Dowd IV.


The price reported is an average of the total transactions executed for the day, with the individual transactions ranging from a low of $244.22 per share to a high of $245.20 per share.

The price reported is an average of the total transactions executed for the day, with the individual transactions ranging from a low of $245.24 per share to a high of $245.89 per share.

These shares are held in the Thene Revocable Living Trust dated September 17, 2010, Tony R. Thene and Holly Thene, Trustees.


Shares owned directly by Ancora Catalyst. Mr. DiSanto, solely by virtue of his position as the Chairman and Chief Executive Officer of Ancora Holdings, the sole member of Ancora Alternatives, the General Partner of Ancora Catalyst, may be deemed to beneficially own the shares owned directly by Ancora Catalyst, for purposes of Section16.Mr.DiSanto expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Shares owned directly by Ancora Merlin. Mr. DiSanto, solely by virtue of his position as the Chairman and Chief Executive Officer of Ancora Holdings, the sole member of Ancora Alternatives, the General Partner of Ancora Merlin, may be deemed to beneficially own the shares owned directly by Ancora Merlin, for purposes ofSection16.Mr.DiSanto expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.


Represents shares to be withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person that arose upon the vesting of certain restricted stock.

/s/ Michael James Lyons by Calla Hackler, as Attorney-in-Fact


These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.

These shares are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $38.26 to $39.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

These shares are held by Versant Vantage II, L.P. ("VV II"). Versant Vantage II GP-GP, LLC ("VV II GP-GP") is the sole general partner of Versant Vantage II GP, L.P. ("VV II GP") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP may be deemed to share voting, investment and dispositive power over the shares held by VV II and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.


1. On August 8, 2025, the reporting person filed a Form 4 which inadvertently reported the purchase of 266 shares of common stock. This amendment updates the Form 4 to reflect the purchase of 2,222 shares of common stock.


In connection with the vesting of previously reported restricted stock units.

The reporting person was granted restricted stock units under the Carpenter Technology Corporation Stock-Based Incentive Compensation Plan for Officers and Key Employees.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging between $2.27 and $2.32. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging between $2.29 and $2.35. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


Class A Common Stock

This transaction was made pursuant to a Rule 10b5-1 trading plan dated May 7, 2025 adopted by the reporting person.

Options vest in three equal installments on each of the first three anniversaries of the date of the grant, subject to earlier vesting in full in limited circumstances as specified in the award agreement. The option was granted on November 19, 2017.


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $239.4900 to $239.9300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $240.5619 to $241.5056 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $241.6750 to $242.6591 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $242.6873 to $243.6340 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $243.7682 to $244.5000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest in three equal annual installments on the first, second and third anniversaries of the grant date.

Amount reported includes unvested RSUs.


Represents shares purchased under Employee Share Purchase Plan.

Effective October 31, 2024, Fundamental Global Inc went through one for twenty-five reverse split of its outstanding common shares.


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

On August 15, 2025, the reporting person was granted 10,108 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on August 25, 2026, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.

/s/ Christina Poler as attorney-in-fact for Emily Dreyer


Common Stock

Common Stock

Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

30% of the shares subject to the restricted stock units vested on February 17, 2024, 15% of the shares subject to the restricted stock units vested on each of August 17, 2024 and February 17, 2025, 20% of the shares subject to the restricted stock units vested on August 17, 2025, and the final vest on February 17, 2026 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2023 to December 31, 2025, subject to the reporting person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on May 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Each restricted stock unit and performance stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.

The restricted stock units vested one-third on August 15, 2023, one-third on August 15, 2024 and the remainder of the award vested on August 15, 2025.

The restricted stock units vested one-third on August 15, 2024, one-third on August 15, 2025 and the remainder of the award will vest on August 15, 2026.

The restricted stock units vested one-third on August 15, 2025, will vest one-third on August 15, 2026 and the remainder of the award will vest on August 15, 2027.

/s/ Laura A. Cleveland as Attorney-in-Fact for Steven Tomsic


common stock

common stock

The number of shares of common stock beneficially owned following the transactions reported herein reflects a correction to the Reporting Person's total share ownership, which was inadvertently overstated by 500 shares on the Form 4 filed June 10, 2025.

This entry represents the number of shares of Viasat, Inc. common stock withheld by the Issuer to satisfy the tax withholding obligation of the Reporting Person. These shares were not sold by the Reporting Person but were instead offset from the total number of vested shares received by the Reporting Person from the Issuer.

The original award was for 20,000 restricted stock units on 08/17/2023. Subject to the Reporting Person's continued employment with the Issuer, the units vest and convert into shares of common stock of the Issuer (on a 1-for-1 basis) in four (4) equal annual installments beginning on 08/17/2024.

Each restricted stock unit represents a contingent right to receive one share of Viasat, Inc. common stock.

The units vest and convert into shares of common stock (on a 1-for-1 basis) at the rate of 34% on August 17, 2026; 33% on June 7, 2027; and 33% on June 7, 2028.

Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of employment or service with the Issuer.


This transaction was executed in multiple trades during the day at prices ranging from $108.88 to $112.58. The weighted-average price is reported above. The Reporting Person hereby undertakes to
provide to the SEC staff, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the trades were made.

/s/ Matthew Yorkavich, attorney-in-fact for Jason Warnick


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on November 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on August 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Paul Fipps by Russell S. Elmer, Attorney-in-Fact


Represents shares of the Issuer's Class A Common Stock issued to the Reporting Person as restricted stock units granted under the Issuer's 2019 Long-Term Stock Incentive Plan. These restricted stock units will vest in three equal annual installments beginning August 15, 2026.

/s/ Avery S. Fischer, Attorney-in-Fact for Robert P. Ranftl


Class A Common Stock

Class A Common Stock

Each restricted stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.

The restricted stock units vested one-third on August 15, 2025,  will vest one-third on August 15, 2026 and the remainder of the award will vest on August 15, 2027.

/s/ Laura A. Cleveland as Attorney-in-Fact for Adam G. Ciongoli


The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Sean D. Mersten, Attorney in Fact for Patrick Plewman


These shares of Common Stock represent the portion of the reporting person's quarterly compensation that the reporting person was required to or elected to receive in the form of shares of Common Stock. The number of shares was calculated based on the closing price of a share of Common Stock on August 14, 2025. Pursuant to the Issuer's Deferred Fee Plan for Directors, the reporting person elected to defer the receipt of 147 of such shares to a future date in accordance with the terms of such plan.

Shares disposed of represent shares withheld by the Issuer to pay taxes due upon vesting of restricted stock.

\s\ Alberto de Cardenas For: Ava L. Parker


Common Stock

Common Stock

Common Stock

The transactions reported on this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

30% of the shares subject to the restricted stock units vested on February 17, 2024, 15% of the shares subject to the restricted stock units vested on each of August 17, 2024 and February 17, 2025, 20% of the shares subject to the restricted stock units vested on August 17, 2025, and the final vest on February 17, 2026 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2023 to December 31, 2025, subject to the reporting person's continued service to the Issuer on each vesting date.

/s/ Kevin Thomas McBride by Russell S. Elmer, Attorney-in-Fact


/s/ William H. Gault by Power of Attorney for Sara M. Momper


/s/ Avery S. Fischer, Attorney-in-Fact for Justin M. Picicci


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A  Common  Stock

Each restricted stock unit and performance stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.

The restricted stock units vested one-third on August 15, 2023, one-third on August 15, 2024 and the remainder of the award  vested on August 15, 2025.

The restricted stock units vested one-third on August 15, 2024, one-third on August 15, 2025 and the remainder of the award will vest on August 15, 2026.

/s/ Laura A. Cleveland as Attorney-in-Fact for John Nallen


This sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

The shares are held by Donald Spetner, Trustee of The IMCR GRAT, dated July 27, 2021.

The shares are held by Donald Spetner, Trustee of The MRCR GRAT, dated July 27, 2021.

The shares are held by Donald Spetner, Trustee of The MRCR GRAT, dated July 27, 2023.

The shares are held by Donald Spetner, Trustee of The IMCR GRAT, dated July 27, 2023.


common stock

Each restricted stock unit represents a contingent right to receive one share of Viasat, Inc. common stock.

Subject to the Reporting Person's election to defer the receipt of the common stock, the units vest and convert into shares of common stock (on a 1-for-1 basis) at the rate of 34% on September 17, 2026; 33% on June 7, 2027; and 33% on June 7, 2028.

Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of employment or service with the Issuer.


Class A Common Stock

Each restricted stock unit represents a contingent right to receive one share of Visa Inc. common stock or a cash equivalent of its value. The restricted stock units vest in two installments: 50% on the second anniversary of the grant date and 50% on the third anniversary of the grant date, subject to earlier vesting in full in limited circumstances as specified in the award agreement. The award was granted on August 15, 2023.


Represents a gift by the Reporting Person


Common Stock

Common Stock

Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on May 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ William R. McDermott by Russell S. Elmer, Attorney-in-Fact


These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

Includes an aggregate of 818,740 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.


\s\ Alberto de Cardenas For: Robert Campbell


Includes shares acquired through dividend reinvestment plan


By K. Rupert Murdoch 2004 Revocable Trust

Class A Common Stock

Each performance stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.

/s/ Laura A. Cleveland as Attorney-in-Fact for Keith Rupert Murdoch


common stock


Shares disposed of represent shares withheld by the Issuer to pay taxes due upon vesting of restricted stock.

\s\ Alberto de Cardenas For: Javier Palomarez


Common Stock

Common Stock

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $4.379 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2]

[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3]

[continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration.

/s/ Halley Gilbert, as attorney-in-fact for Krishnan Viswanadhan


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Each restricted stock unit and performance stock unit represents the equivalent of one share of Fox Corporation's Class A Common Stock.

The restricted stock units vested one-third on August 15, 2023, one-third on August 15, 2024 and the remainder of the award  vested on August 15, 2025.

The restricted stock units vested one-third on August 15, 2024, one-third on August 15, 2025 and the remainder of the award will vest on August 15, 2026.

The restricted stock units vested one-third on August 15, 2025,  will vest one-third on August 15, 2026 and the remainder of the award will vest on August 15, 2027.

/s/ Laura A. Cleveland as Attorney-in-Fact for Lachlan K. Murdoch


Represents a bona fide gift of 600 shares by the Reporting Person to a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code.


Represents shares of the Issuer's Class A Common Stock issued to the Reporting Person as restricted stock units granted under the Issuer's 2019 Long-Term Stock Incentive Plan. These restricted stock units will vest in three equal annual installments beginning August 15, 2026.

/s/ Avery S. Fischer, Attorney-in-Fact for Patrice Louvet


Common Stock

/s/ Halley Gilbert, as attorney-in-fact for David Lubner


\s\ Alberto de Cardenas For: Julia Johnson


/s/ Avery S. Fischer, Attorney-in-Fact for David Lauren


Common Stock

Common Stock

/s/ Halley Gilbert, as attorney-in-fact for John A. Orwin


The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 19, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.79 to $75.76 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The price reported in Column 4 is a weighted average price. These shares of common stock ("Shares") of Team, Inc. (the "Issuer") were purchased in multiple transactions ranging from $18.67 to $19.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price in the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares of common stock ("Shares") of Team, Inc. (the "Issuer") were purchased in multiple transactions ranging from $18.71 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price in the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares of common stock ("Shares") of Team, Inc. (the "Issuer") were purchased in multiple transactions ranging from $18.76 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price in the range set forth in this footnote.


Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on May 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Amit Zavery by Russell S. Elmer, Attorney-in-Fact


common stock

Each restricted stock unit represents a contingent right to receive one share of Viasat, Inc. common stock.

Subject to the Reporting Person's election to defer the receipt of the common stock, the units vest and convert into shares of common stock (on a 1-for-1 basis) at the rate of 34% on September 17, 2026; 33% on June 7, 2027; and 33% on June 7, 2028.

Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of employment or service with the Issuer.


/s/ Avery S. Fischer, Attorney-in-Fact for Halide Alagoz


Shares disposed of represent shares withheld by the Issuer to pay taxes due upon vesting of restricted stock.

\s\ Alberto de Cardenas For: Robert Dwyer


Common Stock

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $4.379 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2]

[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3]

[continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration.

/s/ Halley Gilbert, as attorney-in-fact for Jane Henderson


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

On August 15, 2023, the reporting person was granted 115,474 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. The number of securities reported in columns 5 and 7 includes 1,124 dividend equivalent rights accrued with respect to the underlying restricted stock units.

Jason White, attorney-in-fact for Brian Schell


Class A Common Stock

Each restricted stock unit represents a contingent right to receive one share of Visa Inc. common stock or a cash equivalent of its value. The restricted stock units vest in three equal installments on each of the first three anniversaries of the date of the grant, subject to earlier vesting in full in limited circumstances as specified in the award agreement. The award was granted on August 15, 2023.


Common Stock

/s/ Halley Gilbert, as attorney-in-fact for Abraham Bassan


Common Stock

Common Stock

Common Stock

The transaction(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

30% of the shares subject to the restricted stock units vested on February 17, 2024, 15% of the shares subject to the restricted stock units vested on each of August 17, 2024 and February 17, 2025, 20% of the shares subject to the restricted stock units vested on August 17, 2025, and the final vest on February 17, 2026 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2023 to December 31, 2025, subject to the reporting person's continued service to the Issuer on each vesting date.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Jacqueline P. Canney by Russell S. Elmer, Attorney-in-Fact


\s\ Alberto de Cardenas For: Ernst Csiszar


Indirect Owner (Custodial Account for minor children)

Indirect Owner (The David O. Watson Irrevocable Trust of 2023)

This was a scheduled sale from 10B5-1 trading plan dated March 3, 2025.

This represents a custodial account held by the reporting person for the sole benefit of his minor children.

The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.


/s/ Tim Whisler, on behalf of and as attorney-in-fact for Andrew M. Watterson


These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

Includes an aggregate of 235,623 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 85,220 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.


American Depositary Shares

Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.

ADSs acquired upon vesting of Restricted Share Units ("RSUs").

Each RSU represents a contingent right to receive one ADS.

These ADSs were sold automatically to cover taxes upon vesting of RSUs.

The RSUs vest in equal annual installments over five years beginning on 08/15/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.


American Depositary Shares

The RSUs vest in equal annual installments over five years beginning on 08/17/2021, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.


Common Stock, par value $0.001 per share

Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units.

/s/ Kate Salley, Attorney-in-Fact for Michael Adler


Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.


/s/ Kate Salley, Attorney-in-Fact for Peter Anastos


The reported transaction represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 491 Restricted Stock Units on August 15, 2025.

Includes 26.855 shares acquired under the Analog Devices, Inc. Amended & Restated 2022 Employee Stock Purchase Plan on June 6, 2025.

/s/ Shelly Shaw, General Counsel, by Power of Attorney


Common Stock

Consists of 14,765 restricted stock units that vest in equal installments over a three-year period.

The option vests in three equal annual installments beginning on August 15, 2026.


common stock


Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 777 RSUs.

Includes 72,447 restricted stock units.


The reported transaction represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 5,952 Restricted Stock Units on August 15, 2025.

Shares held by the Vincent Roche 2023 Grantor Retained Annuity Trust dated August 25, 2023.

Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.


Common Stock

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $4.379 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2]

[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3]

[continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration.

/s/ Halley Gilbert, as attorney-in-fact for Reid Huber


COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

COMMON

TOTAL OPTIONS AS OF REPORT

WARRANT WAS NOT CAPTURED ON LAST FILING


/s/ Kate Salley, Attorney-in-Fact for Kathleen Pai


These shares were withheld to satisfy tax withholding obligations in connection with the vesting of previously awarded deferred stock.

The reporting person indirectly beneficially owns the indicated shares of State Street common stock under State Street's 401(k) plan, based on a plan statement dated as of August 15, 2025. The plan accounts for interest in units consisting of shares of State Street common stock, dividend equivalents and a small amount of cash. As a result, the number of underlying shares may fluctuate from time to time.

/s/ Shannon C. Stanley, Attorney-in-fact


The reported transaction represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 2,291 Restricted Stock Units on August 15, 2025.


The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 5, 2024.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.79 to $14.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.95 to $14.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The shares are held of record by Dustin A. Moskovitz TTEE Dustin A. Moskovitz Trust DTD 12/27/05.


Non-Qualified Stock Option (Right to Buy)

Common Stock

/s/ John O. Faurescu, attorney-in-fact for Dr. Malik


Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units.

/s/ Kate Salley, Attorney-in-Fact for Timothy O'Brien


The reported transaction represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 416 Restricted Stock Units on August 15, 2025.

Includes 26.855 shares acquired under the Analog Devices, Inc. Amended & Restated 2022 Employee Stock Purchase Plan on June 6, 2025.


Common Stock

Common Stock

Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

30% of the shares subject to the restricted stock units vested on February 17, 2024, 15% of the shares subject to the restricted stock units vested on each of August 17, 2024 and February 17, 2025, 20% of the shares subject to the restricted stock units vested on August 17, 2025, and the final vest on February 17, 2026 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2023 to December 31, 2025, subject to the reporting person's continued service to the Issuer on each vesting date.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on May 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Gina Mastantuono by Russell S. Elmer, Attorney-in-Fact


Common Stock

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On August 18, 2025, Parent and Merger Sub completed a tender offer (the "Tender Offer") pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $4.379 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2]

[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, effective as of August 19, 2025 (the "Effective Time"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger").

Pursuant to the terms of the Merger Agreement, immediately prior to the time at which Parent first irrevocably accepts for purchase the Shares tendered in the Tender Offer, each restricted stock unit award with respect to Shares that is, at the time of determination, subject to vesting or forfeiture conditions ("RSU Award") that is outstanding as of immediately prior thereto, shall (a) accelerate and become fully vested, and (b) by virtue of the Merger automatically (except as otherwise provided in the Merger Agreement) and without any action on the part of the Issuer, Parent or the holder thereof, be canceled and terminated and converted into the right to receive [continues to Footnote 4]

[continues from Footnote 3] (i) an amount in cash without interest, subject to any applicable tax withholding, equal to the product of the number of Shares underlying such RSU Award immediately prior to the Effective Time and $4.379 in cash, plus (ii) one CVR with respect to each Share subject to such RSU Award immediately prior to the Effective Time.

As of immediately prior to and conditioned upon the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the Effective Time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the Effective Time [continues to Footnote 6]

[continues from Footnote 5] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration.

Title: Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer

/s/ Halley Gilbert, as attorney-in-fact for Anup Radhakrishnan


Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 3,722 RSUs.

Includes 228,813 restricted stock units.


Common Stock

Common Stock

Between 0% and 250% of the target number of performance-based restricted stock units ("PRSU") may be earned depending on (a) the return on AMD's stock price relative to the return of each of the component companies comprising the S&P 500 Index, subject to adjustments, over the performance period that begins August 15, 2025 and ends on August 15, 2028, (b) the absolute return on AMD's stock price over the performance period, and (c) the percentage (if any) by which AMD's 2027 fiscal year non-GAAP earnings per share exceeds AMDs 2025 fiscal year non-GAAP earnings per share. Vesting of any earned PRSUs is generally subject to the Reporting Person's continued employment and/or service with AMD through August 15, 2028 (or the one-year anniversary of a change in control, if earlier).

The actual number of PRSUs that may be earned, if at all, will be determined by the Compensation and Leadership Resources Committee (the "Committee") based on AMD's actual performance with respect to the performance vesting conditions described in footnote 1, above. Earned and vested PRSUs will generally be settled on the later of August 15, 2028, or the date following the Committee's determination of performance.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on August 15, 2026, and then quarterly thereafter until August 15, 2029.

/s/Linda Lam by Power of Attorney for Philip Matthew Carter


Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units.

/s/ Kate Salley, Attorney-in-Fact for John Pagliuca


Mr. Vollmer purchased these shares in an open market transaction.

Anthony D. Foti, Attorney-in-Fact for Jason L. Vollmer


Represents aggregate shares withheld to satisfy tax withholding obligations on an aggregate of 4,476 Restricted Stock Units that vested on August 15, 2025.

Includes 26.855 shares acquired under the Analog Devices, Inc. Amended & Restated 2022 Employee Stock Purchase Plan on June 6, 2025.


These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of an RSU award granted to the reporting person on September 1, 2021.

This transaction was a bona fide gift with no payment in consideration. Exempt from Section 16(b) of the Act pursuant to Rule 16b-5 promulgated under the Act.


The reported transaction represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 1,458 Restricted Stock Units on August 15, 2025.


Common Stock

Common Stock

Common Stock

Common Stock

Each performance-based restricted stock unit ("PRSU") represents a contingent right to receive one share of AMD's common stock.

Reflects shares issued in settlement of PRSUs earned and vested under PRSU award granted on August 9, 2022.

The options vest 1/4  on August 15, 2026 and then quarterly thereafter until August 15, 2029.

Between 0% and 250% of the target number of PRSUs may be earned depending on (a) the return on AMD's stock price relative to the return of each of the component companies comprising the S&P 500 Index, subject to adjustments, over the performance period that begins August 15, 2025 and ends on August 15, 2028, (b) the absolute return on AMD's stock price over the performance period, and (c) the percentage (if any) by which AMD's 2027 fiscal year non-GAAP earnings per share exceeds AMDs 2025 fiscal year non-GAAP earnings per share. Vesting of any earned PRSUs is generally subject to the Reporting Person's continued employment and/or service with AMD through August 15, 2028 (or the one-year anniversary of a change in control, if earlier).

The actual number of PRSUs that may be earned, if at all, will be determined by the Compensation and Leadership Resources Committee (the "Committee") based on AMD's actual performance with respect to the performance vesting conditions described in footnote 4, above. Earned and vested PRSUs will generally be settled on the later of August 15, 2028, or the date following the Committee's determination of performance.


AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC. AQR Arbitrage, LLC is deemed to be controlled by AQR Capital Management, LLC. AQR Capital Management, LLC and AQR Arbitrage, LLC act as investment manager to each of AQR Global Alternative Investment Offshore Fund, L.P., AQR Corporate Arbitrage Master Account, L.P., AQR TA Global Alpha Fund, L.P., AQR Absolute Return Master Account, L.P., AQR Apex MS Master Account, L.P., AQR TA Legacy Fund, LLC, AQR Arbitrage MA Offshore Fund, L.P. AQR Capital Management, LLC serves as the investment manager, and AQR Arbitrage, LLC as sub-advisor, to the AQR Diversified Arbitrage Fund, an open-end registered investment company, and to the AQR UCITS Funds - AQR Corporate Arbitrage UCITS Fund.

AQR Capital Management GP Ltd. is the general partner of AQR Global Alternative Investment Offshore Fund, L.P. AQR Corporate Arbitrage GP, LLC is the general partner of AQR Corporate Arbitrage Master Account, L.P. AQR Tax Advantaged GP II, LLC is the general partner of AQR TA Global Alpha Fund, L.P. AQR Principal Global Asset Allocation, LLC is the general partner of AQR Absolute Return Master Account, L.P. AQR Apex MS GP, LLC is the general partner of AQR Apex MS Master Account, L.P. AQR Capital Management II, LLC is the general partner of AQR TA Legacy Fund, LLC. CNH Principal Partners I, LLC is the general partner of AQR Arbitrage MA Offshore Fund, L.P.


/s/ Kate Salley, Attorney-in-Fact for Frank Colletti


Class B Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

This award is fully vested.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock.

The securities are held by a family trust, of which the reporting person's spouse is the trustee. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.


Common Stock

Common Stock

Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2023 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2023 until December 31, 2023, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 22, 2024.

30% of the shares subject to the restricted stock units vested on February 17, 2024, 15% of the shares subject to the restricted stock units vested on each of August 17, 2024 and February 17, 2025, 20% of the shares subject to the restricted stock units vested on August 17, 2025, and the final vest on February 17, 2026 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2023 to December 31, 2025, subject to the reporting person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 17, 2023, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/12th of the total shares quarterly, with the first vesting having occurred on May 15, 2025, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Nicholas Tzitzon by Russell S. Elmer, Attorney-in-Fact


The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

Shares held by The Delsanto Family Trust, for which the reporting person serves as a trustee.


Reflects shares of Issuer's common stock withheld to satisfy tax withholding obligations upon vesting of time-based stock units.


Common Stock

Each restricted stock unit represents a contingent right to receive one share of ALOT common stock.

The restricted stock units vest and settle on August 15, 2028.

/s/ Daniel Clevenger, by Power of Attorney


Non-Employee Stock Option (Right to Buy)

Common Stock

Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock.

This transaction was executed in multiple trades at prices ranging from $283.146 to $283.165, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date.

/s/ Corinne Lawson, as Attorney-in-Fact for Suzanne M. Vautrinot


Common

Each restricted stock unit represents a contingent right to receive one share of Kellanova common stock.


Common Stock


Common Stock

Common Stock

Common Stock

Common Stock

This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.64 to $14.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the
Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.74 to $13.987 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the
Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The RSUs vest 25% on February 18, 2023, and then 6.25% of the total shares vest on each quarterly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

The RSUs vest in equal quarterly installments over four years beginning on May 18, 2022, subject to the continuing employment of the Reporting
Person with the Issuer on each vesting date.

The RSUs vest 25% on February 18, 2024, and then 6.25% of the total shares vest on each quarterly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

The RSUs vest in equal quarterly installments over four years beginning on May 18, 2023, subject to the continuing employment of the Reporting
Person with the Issuer on each vesting date.


Common

Represents share held in an IRA account of the reporting person's mother over which the reporting person has been granted power of attorney and with respect to which he is one of several beneficiaries. The reporting person disclaims beneficial ownership of these securities.


Common Stock

Common Stock

Common Stock

The options vest 1/4  on August 15, 2026 and then quarterly thereafter until August 15, 2029.

Between 0% and 250% of the target number of performance-based restricted stock units ("PRSU") may be earned depending on (a) the return on AMD's stock price relative to the return of each of the component companies comprising the S&P 500 Index, subject to adjustments, over the performance period that begins August 15, 2025 and ends on August 15, 2028, (b) the absolute return on AMD's stock price over the performance period, and (c) the percentage (if any) by which AMD's 2027 fiscal year non-GAAP earnings per share exceeds AMDs 2025 fiscal year non-GAAP earnings per share. Vesting of any earned PRSUs is generally subject to the Reporting Person's continued employment and/or service with AMD through August 15, 2028 (or the one-year anniversary of a change in control, if earlier).

The actual number of PRSUs that may be earned, if at all, will be determined by the Compensation and Leadership Resources Committee (the "Committee") based on AMD's actual performance with respect to the performance vesting conditions described in footnote 2, above. Earned and vested PRSUs will generally be settled on the later of August 15, 2028, or the date following the Committee's determination of performance.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of AMD's common stock.

The RSUs vest 1/4 on August 15, 2026 and then quarterly thereafter until August 15, 2029.

/s/Linda Lam by Power of Attorney for Philip Guido


Common Stock

On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 5,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance.


Common Stock

On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance.


Common stock

Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director of the annual term.

Total shares beneficially owned reflect a 2-for-1 stock split effected on June 20, 2025.

Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.

/s/ Ewelina Kemp, Attorney-in-Fact for Larry Weber


Common Stock

Each restricted stock unit represents a contingent right to receive one share of ALOT common stock.

The restricted stock units vest and settle on August 15, 2028.


Common Stock

The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 225,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance.


Class A Common Stock

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 2, 2024.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.67 to $75.66, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.67 to $76.66, inclusive.

The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.


Common Stock

Common Stock

Common Stock

/s/ Ramune M. Kligys by PoA of Stephen Edward Hull


Reflects the forfeiture of shares of restricted stock of Clearway Energy, Inc. (the "Issuer") previously granted by Clearway Energy Group LLC ("Clearway Energy Group") under its Long Term Equity Incentive Program to one or more of its employees.

The securities reported herein are held directly by Clearway Energy Group. GIP III Zephyr Acquisition Partners, L.P. ("Zephyr") is the sole member of Clearway Energy Group. Zephyr Holdings GP, LLC ("Zephyr GP") is the general partner of Zephyr.

TotalEnergies Renewables USA, LLC holds 50% of the equity interests in Zephyr GP. TotalEnergies Holdings USA, Inc. is the sole shareholder of TotalEnergies Delaware, Inc., which is the sole member of TotalEnergies Renewables USA, LLC. TotalEnergies Gestion USA SARL, which is a direct wholly owned subsidiary of TotalEnergies SE, is the sole shareholder of TotalEnergies Holdings USA, Inc. Each of the foregoing entities is a "Reporting Person" and may be deemed to beneficially own the securities reported herein; however, each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. Solely for purposes of Section 16 of the Exchange Act, each Reporting Person may be deemed a "director by deputization".


Common Stock

Common Stock

Transaction to exercise previously granted non-qualified stock options expiring on February 25, 2026 and effectuated pursuant to Rule 10b5-1 Trading Plan adopted September 10, 2024.

Represents shares of common stock.

Sale of common stock effectuated pursuant to Rule 10b5-1 Trading Plan adopted September 10, 2024 solely to cover option costs, tax obligations, commissions and fees incident to the exercise of non-qualified stock options granted in accordance with Rule 16b-3 and the delivery of shares in respect thereof.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.375 to $89.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.95 to $88.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.91 to $87.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.91 to $88.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

Represents restricted stock units.

The options vested in four equal installments on each of the first four anniversaries of February 27, 2020.

/s/ Paul F. Cash as Attorney-in-Fact for Geoffrey A. Ballotti


Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 9, 2024.

Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $25.80 to $26.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes (i) 46,750 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 58,281 unvested RSUs and 31,250 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 112,797 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4 and (iv) 10,417 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.


Includes 4,097 shares acquired under Omnicom's employee stock purchase plan.

/s/ Eric J. Cleary, Attorney in Fact for Andrew Castellaneta


The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2022, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 15, 2025. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The sale does not represent a discretionary trade by the reporting person.

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2021, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 15, 2025. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The sale does not represent a discretionary trade by the reporting person.

/s/ Jon Ayotte, as attorney-in-fact for Joseph Sanborn


/s/ Eric J. Cleary, Attorney in Fact for Louis F. Januzzi


The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2021, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 15, 2025. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The sale does not represent a discretionary trade by the reporting person.


Common Shares

Common Shares

Common Shares

Common Shares

Restricted stock units convert into common stock on a one-for-one basis.

On November 15, 2021, the reporting person was granted 1,110 restricted stock units, vesting as to twenty-five percent (25%) of the shares on November 15, 2022 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

On July 1, 2022, the reporting person was granted 1,720 restricted stock units, vesting as to twenty-five percent (25%) of the shares on May 15, 2023 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

On July 13, 2023, the reporting person was granted 2,341 restricted stock units, vesting as to twenty-five percent (25%) of the shares on May 15, 2024 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

On July 1, 2024, the reporting person was granted 2,798 restricted stock units, vesting as to twenty-five percent (25%) of the shares on May 15, 2025 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

/s/ Bryan Tham, Attorney-in-Fact for Daniel De Lorenzo


/s/ Eric J. Cleary, Attorney in Fact for Daryl Simm


Reflects the forfeiture of shares of restricted stock of the Issuer previously granted by Clearway Energy Group LLC ("Clearway Energy Group") under its Long Term Equity Incentive Program to one or more of its employees.

Reflects securities held directly by Clearway Energy Group. Zephyr Holdings GP, LLC ("Zephyr GP") is the general partner of GIP III Zephyr Acquisition Partners, L.P. ("Zephyr") which is the sole member of Clearway Energy Group. Zephyr GP is owned by GIP III Zephyr Midco Holdings, L.P. ("Midco") and TotalEnergies Renewables USA, LLC. Global Infrastructure Investors III, LLC ("Global Investors") is the sole general partner of Global Infrastructure GP III, L.P. ("Global GP"), which is the general partner of Midco. As a result, each of Zephyr GP, Zephyr, Midco, Global GP and Global Investors (the "GIP Entities") may be deemed to share beneficial ownership of the securities owned by Clearway Energy Group.

Adebayo Ogunlesi, Michael McGhee, Rajaram Rao, Deepak Agrawal, Julie Ashworth, Jonathan Bram, William Brilliant, Matthew Harris, Tom Horton, Sugam Mehta and Salim Samaha, as the voting members of the Investment Committee of Global Investors, may be deemed to share beneficial ownership of the Issuer securities beneficially owned by Global Investors. Such individuals expressly disclaim any such beneficial ownership.

BlackRock Portfolio Management LLC and the GIP Entities disclaim beneficial ownership of the securities reported herein, except to the extent of their respective pecuniary interest therein, if any, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended, BlackRock Portfolio Management LLC and the GIP Entities state that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the securities reported herein for purposes of Section 16 or for any other purpose.

In accordance with SEC Release No. 34-39538 (January 12, 1998), BlackRock Portfolio Management LLC is reporting Issuer securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. This filing does not include Issuer securities, if any, beneficially owned by other business units whose beneficial ownership of securities is disaggregated from that of the Reporting Business Units in accordance with such release.

BlackRock Portfolio Management LLC By: /s/ Julie Ashworth, Authorized Signatory


Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on August 15, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on October 26, 2021. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards are fully vested.

Consists of 66,222 shares of common stock and 89,242 RSUs.

/s/ Junlin Ho, Attorney-in-Fact for Caryn Parlavecchio


Common Shares

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025.

/s/ Elizabeth Ryland Waldinger, attorney-in-fact


Represents a restricted stock unit award ("RSU Award") granted to the Reporting Person under the Issuer's 2018 Equity Incentive Plan (the "Plan"). The RSU Award vests in one-third increments on each of the first three anniversaries of the grant date, subject to continued employment or as otherwise provided in the Plan or the applicable form of RSU Award Agreement.


Common Stock

This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024.

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.24 to $49.11 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

This option was granted on February 14, 2024 and vests over four years, with 25% of the shares underlying the option vested on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.


Common Shares

Common Shares

Common Shares

Restricted stock units convert into common stock on a one-for-one basis.

On July 1, 2022, the reporting person was granted 16,758 restricted stock units. Restricted stock unit awards shall vest as to twenty-five percent (25%) of the shares May 15, 2023 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

On July 13, 2023, the reporting person was granted 16,058 restricted stock units. Restricted stock unit awards shall vest as to twenty-five percent (25%) of the shares May 15, 2024 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

On July 1, 2024, the reporting person was granted 11,195 restricted stock units. Restricted stock unit awards shall vest as to twenty-five percent (25%) of the shares May 15, 2025 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.

/s/ Bryan Tham, Attorney-in-Fact for Elizabeth M O'Callahan